All stock lists
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
Healthcare · Biotechnology
2.15-0.01 (-0.23%)
Insider Score
––Not scored
OVID Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
OVID Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 733.00 K | 0.00 | 718.00 K | 132.00 K | 6.27 M |
| Revenue Growth (YoY) | -88.31 % | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| SG&A Expense | 6.47 M | 6.67 M | 6.42 M | 6.79 M | 4.88 M |
| R&D Expense | 9.96 M | 11.18 M | 6.59 M | 5.87 M | 6.46 M |
| Operating Expenses | 16.43 M | 17.85 M | 13.01 M | 12.65 M | 11.35 M |
| Operating Income | -15.70 M | -17.85 M | -12.29 M | -12.52 M | -5.07 M |
| Pretax Income | -15.01 M | -16.99 M | 9.66 M | -12.16 M | -4.68 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -15.01 M | -16.99 M | 9.66 M | -12.16 M | -4.68 M |
| EPS (Basic) | -0.08 | -0.12 | 0.06 | -0.17 | -0.06 |
| EPS (Diluted) | -0.08 | -0.12 | 0.06 | -0.17 | -0.06 |
| Shares Outstanding | 197.45 M | 136.17 M | 81.67 M | 71.12 M | 71.11 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.